SCHEMBL28692111

SCHEMBL28692111

Fc1ccc(OC[C@H]2CCO2)c(Br)c1C1OCCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.41
SLC6A4 P31645 3/20 0.41
SCN9A Q15858 1/20 0.34
TSHR P16473 1/20 0.33
DRD4 P21917 2/20 0.33
RET P07949 1/20 0.32
KIF5B P33176 1/20 0.32
KCNH2 Q12809 1/20 0.32
EGFR P00533 1/20 0.32
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
KMT2A Q03164 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GLA P06280 1/20 0.31
ERBB2 P04626 1/20 0.31
EPHA2 P29317 1/20 0.31
EPHB4 P54760 1/20 0.31
ADRB2 P07550 1/20 0.31
HTR1A P08908 1/20 0.31
SLC6A2 P23975 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28692115 1.00 HTR2A (0.41) HTR2ASLC6A4SCN9ATSHRDRD4
SCHEMBL22445376 0.90 ALDH1A1 (0.41) HTR2ASLC6A4SCN9ATSHRDRD4
SCHEMBL22445377 0.90 ALDH1A1 (0.41) HTR2ASLC6A4SCN9ATSHRDRD4
SCHEMBL26111042 0.77 HTR2A (0.36) HTR2ASLC6A4ALDH1A1SLC6A2HTR2B
SCHEMBL10188111 0.69 DRD4 (0.41) HTR2ASLC6A4SCN9ATSHRDRD4
SCHEMBL22445367 0.68
SCHEMBL30140391 0.67 HTR2A (0.37) HTR2ASLC6A4SCN9ATSHRDRD4
SCHEMBL13696464 0.66 ALDH1A1 (0.47) HTR2ASLC6A4SCN9ADRD4ALDH1A1
SCHEMBL2834264 0.66 SMN1; SMN2 (0.42) TSHRDRD4ALDH1A1
SCHEMBL23847921 0.66 EGLN2 (0.43) HTR2ASLC6A4SCN9ATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114144230-B Macrocyclic azolopyridine derivatives as EED and PRC2 modulators 弗尔康医疗公司 2024-04-23 CN disclosed
CN-114144230-A Macrocyclic azolopyridine derivatives as EED and PRC2 modulators 弗尔康医疗公司 2022-03-04 CN disclosed